Hyaluronic Acid-based Dermal Fillers Market Size, Share & Trends Analysis Report By Application (Wrinkle Removal, Lip Augmentation, Rhinoplasty), By Product, By Region, And Segment Forecasts, 2024 - 2030
Hyaluronic Acid-based Dermal Fillers Market Growth & Trends
The global hyaluronic acid-based dermal fillers market size is anticipated to reach at USD 8.24 billion by 2030 and is projected to grow at a CAGR of 10.5% from 2024 to 2030, based on a new report by Grand View Research, Inc. The increasing demand for minimally invasive procedures, growing geriatric population, increasing awareness & concern for younger skin and advancement in technology are key factors driving the market growth.
The global ageing population is increasing. By 2030, 1 in 6 persons globally will be above 60 years old or over with total elder population growing from one 1 to 1.4 billion. In the U.S., it is estimated that one fourth of the people will be above 65 by 2060. Currently the middle-income countries are witnessing huge change with two-thirds of global population over 60 years would be from middle-income countries.
However, the higher cost of market is restraining the market opportunities. The HA-based dermal fillers are available in syringes of 1ml costing USD 600-1000 per syringe. Most of the times a dosage of minimum 2 syringes is required, taking the cost of treatment to USD 1600-2000 which is quite high. The high cost of products makes it difficult for the population of low- medium-income countries.
Hyaluronic Acid-based Dermal Fillers Market Report Highlights
- The single-phase products segment held the market with the largest revenue share of 54.76% in 2023, owing to the benefits like better effectiveness & offered by these products
- Based on application, the wrinkle removal segment led the market with the largest revenue share of 29.53% in 2023. This can be attributed to the increasing spending on cosmetic procedures and the advent of technology for Wrinkle Removal suing HA-based fillers. Wrinkle Removal is the most common skin problems, resulting higher demand for the segment
- North America dominated the market with the largest revenue share of in 2023. This can be attributed to favorable government policies, a rise in the number of plastic surgery procedures and an growing ageing population in the region For instance, as per the Statistics Canada's population statistics published in September 2021, the total population above 60 years of age in Canada is 96, 88,677
- The Asia Pacific market is expected to grow at the fastest CAGR during the forecast period, owing to the rapid economic growth in nation like Japan, China & South Korea and improvement in healthcare infrastructure in the region
- Allergan (AbbVie), is a one of the major global market leaders. This can be attributed to market presence of Juvederm, a HA based dermal filler by the company for long time and better performance of product despite new products being introduced. The company's has powerful product portfolio of HA based dermal fillers & focuses on introducing innovative products into in market
- Chapter 1 Hyaluronic Acid-based Dermal Fillers Market: Methodology and Scope
- 1.1 Market Segmentation & Scope
- 1.1.1 Product
- 1.1.2 Application
- 1.1.3 Regional Scope
- 1.1.4 Estimates and Forecast Timeline
- 1.2 Research Methodology
- 1.3 Information Procurement
- 1.3.1 Purchased Database
- 1.3.2 GVR’s Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Primary Research
- 1.3.5 Details of Primary Research
- 1.4 Information or Data Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Commodity Flow Analysis
- 1.7 List of Secondary Sources
- 1.8 List of Abbreviations
- 1.9 Objectives
- 1.9.1 Objective 1
- 1.9.2 Objective 2
- 1.9.3 Objective 3
- Chapter 2 Hyaluronic Acid-based Dermal Fillers Market: Executive Summary
- 2.1 Market Outlook
- 2.2 Segment Outlook
- 2.2.1 Product
- 2.2.2 Application
- 2.2.3 Region
- 2.3 Competitive Insights
- Chapter 3 Hyaluronic Acid-based Dermal Fillers Market: Variables, Trends & Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Parent market outlook
- 3.2 Market Dynamics
- 3.2.1 Market Driver Analysis
- 3.2.1.1 Growing Aging Population
- 3.2.1.2 Increasing Awareness and Acceptance of Aesthetic Treatments
- 3.2.1.3 Technological Advancements
- 3.2.2 Market Restraint Analysis
- 3.2.3 Regulatory Contraints
- 3.2.4 High Cost of Procedures
- 3.3 Business Environment Analysis Tools
- 3.3.1 Porter’s five forces analysis
- 3.3.1.1 Bargaining power of buyers: Low
- 3.3.1.2 Bargaining power of suppliers: Moderate
- 3.3.1.3 Competitive Rivalry: High
- 3.3.1.4 Threat of new entrants: Moderate
- 3.3.1.5 Threat of substitutes: Low
- 3.3.2 SWOT Analysis, by PESTEL
- 3.3.2.1 Political & legal
- 3.3.2.2 Economic
- 3.3.2.3 Technological
- 3.4 Qualitative Analysis: Impact of COVID-19 on Hyaluronic Acid-based Dermal Fillers Market Market
- Chapter 4. Hyaluronic Acid-based Dermal Fillers Market: Product Estimates & Trend Analysis
- 4.1. Hyaluronic Acid-based Dermal Fillers Market: Product Dashboard
- 4.2. Hyaluronic Acid-based Dermal Fillers Market: Product Movement Analysis
- 4.3. Hyaluronic Acid-based Dermal Fillers Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. Single-Phase Product
- 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5. Duplex Product
- 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 5. Hyaluronic Acid-based Dermal Fillers Market: Application Estimates & Trend Analysis
- 5.1. Hyaluronic Acid-based Dermal Fillers Market: Application Dashboard
- 5.2. Hyaluronic Acid-based Dermal Fillers Market: Application Movement Analysis
- 5.3. Hyaluronic Acid-based Dermal Fillers Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 5.4. Wrinkle Removal
- 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5. Lip Augmentation
- 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.6. Rhinoplasty
- 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.7. Others
- 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 6. Hyaluronic Acid-based Dermal Fillers Market: Regional Estimates & Trend Analysis by Country, Type & Therapy
- 6.1. Hyaluronic Acid-based Dermal Fillers Market: Regional Dashboard
- 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
- 6.3. North America
- 6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.3.2. U.S.
- 6.3.2.1. Key country dynamics
- 6.3.2.2. Regulatory framework/ reimbursement structure
- 6.3.2.3. Competitive scenario
- 6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.3. Canada
- 6.3.3.1. Key country dynamics
- 6.3.3.2. Regulatory framework/ reimbursement structure
- 6.3.3.3. Competitive scenario
- 6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4. Europe
- 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.4.2. UK
- 6.4.2.1. Key country dynamics
- 6.4.2.2. Regulatory framework/ reimbursement structure
- 6.4.2.3. Competitive scenario
- 6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.3. Germany
- 6.4.3.1. Key country dynamics
- 6.4.3.2. Regulatory framework/ reimbursement structure
- 6.4.3.3. Competitive scenario
- 6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.4. France
- 6.4.4.1. Key country dynamics
- 6.4.4.2. Regulatory framework/ reimbursement structure
- 6.4.4.3. Competitive scenario
- 6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.5. Italy
- 6.4.5.1. Key country dynamics
- 6.4.5.2. Regulatory framework/ reimbursement structure
- 6.4.5.3. Competitive scenario
- 6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.6. Spain
- 6.4.6.1. Key country dynamics
- 6.4.6.2. Regulatory framework/ reimbursement structure
- 6.4.6.3. Competitive scenario
- 6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.7. Sweden
- 6.4.7.1. Key country dynamics
- 6.4.7.2. Regulatory framework/ reimbursement structure
- 6.4.7.3. Competitive scenario
- 6.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.8. Norway
- 6.4.8.1. Key country dynamics
- 6.4.8.2. Regulatory framework/ reimbursement structure
- 6.4.8.3. Competitive scenario
- 6.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.9. Denmark
- 6.4.9.1. Key country dynamics
- 6.4.9.2. Regulatory framework/ reimbursement structure
- 6.4.9.3. Competitive scenario
- 6.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5. Asia Pacific
- 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.5.2. China
- 6.5.2.1. Key country dynamics
- 6.5.2.2. Regulatory framework/ reimbursement structure
- 6.5.2.3. Competitive scenario
- 6.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5.3. Japan
- 6.5.3.1. Key country dynamics
- 6.5.3.2. Regulatory framework/ reimbursement structure
- 6.5.3.3. Competitive scenario
- 6.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5.4. India
- 6.5.4.1. Key country dynamics
- 6.5.4.2. Regulatory framework/ reimbursement structure
- 6.5.4.3. Competitive scenario
- 6.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5.5. Australia
- 6.5.5.1. Key country dynamics
- 6.5.5.2. Regulatory framework/ reimbursement structure
- 6.5.5.3. Competitive scenario
- 6.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5.6. Thailand
- 6.5.6.1. Key country dynamics
- 6.5.6.2. Regulatory framework/ reimbursement structure
- 6.5.6.3. Competitive scenario
- 6.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5.7. South Korea
- 6.5.7.1. Key country dynamics
- 6.5.7.2. Regulatory framework/ reimbursement structure
- 6.5.7.3. Competitive scenario
- 6.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
- 6.6. Latin America
- 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.6.2. Brazil
- 6.6.2.1. Key country dynamics
- 6.6.2.2. Regulatory framework/ reimbursement structure
- 6.6.2.3. Competitive scenario
- 6.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
- 6.6.3. Mexico
- 6.6.3.1. Key country dynamics
- 6.6.3.2. Regulatory framework/ reimbursement structure
- 6.6.3.3. Competitive scenario
- 6.6.3.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
- 6.6.4. Argentina
- 6.6.4.1. Key country dynamics
- 6.6.4.2. Regulatory framework/ reimbursement structure
- 6.6.4.3. Competitive scenario
- 6.6.4.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
- 6.7. MEA
- 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.7.2. Saudi Arabia
- 6.7.2.1. Key country dynamics
- 6.7.2.2. Regulatory framework/ reimbursement structure
- 6.7.2.3. Competitive scenario
- 6.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
- 6.7.3. South Africa
- 6.7.3.1. Key country dynamics
- 6.7.3.2. Regulatory framework/ reimbursement structure
- 6.7.3.3. Competitive scenario
- 6.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
- 6.7.4. UAE
- 6.7.4.1. Key country dynamics
- 6.7.4.2. Regulatory framework/ reimbursement structure
- 6.7.4.3. Competitive scenario
- 6.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
- 6.7.5. Kuwait
- 6.7.5.1. Key country dynamics
- 6.7.5.2. Regulatory framework/ reimbursement structure
- 6.7.5.3. Competitive scenario
- 6.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
- Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Company/Competition Categorization
- 7.3. Vendor Landscape
- 7.3.1. Key company market share analysis, 2023
- 7.3.2. Allergan; Galderma Laboratories
- 7.3.2.1. Company overview
- 7.3.2.2. Financial performance
- 7.3.2.3. Type benchmarking
- 7.3.2.4. Strategic initiatives
- 7.3.3. Merz Pharmaceuticals
- 7.3.3.1. Company overview
- 7.3.3.2. Financial performance
- 7.3.3.3. Type benchmarking
- 7.3.3.4. Strategic initiatives
- 7.3.4. Genzyme Corporation
- 7.3.4.1. Company overview
- 7.3.4.2. Financial performance
- 7.3.4.3. Type benchmarking
- 7.3.4.4. Strategic initiatives
- 7.3.5. Anika Therapeutics Inc.
- 7.3.5.1. Company overview
- 7.3.5.2. Financial performance
- 7.3.5.3. Type benchmarking
- 7.3.5.4. Strategic initiatives
- 7.3.6. LG Life Sciences
- 7.3.6.1. Company overview
- 7.3.6.2. Financial performance
- 7.3.6.3. Type benchmarking
- 7.3.6.4. Strategic initiatives
- 7.3.7. LTD (LG Chem)
- 7.3.7.1. Company overview
- 7.3.7.2. Financial performance
- 7.3.7.3. Type benchmarking
- 7.3.7.4. Strategic initiatives
- 7.3.8. Bio plus Co. Ltd.
- 7.3.8.1. Company overview
- 7.3.8.2. Financial performance
- 7.3.8.3. Type benchmarking
- 7.3.8.4. Strategic initiatives
- 7.3.9. Sculpt Luxury
- 7.3.9.1. Company overview
- 7.3.9.2. Financial performance
- 7.3.9.3. Type benchmarking
- 7.3.9.4. Strategic initiatives
- 7.3.10. Dermal Fillers Ltd.
- 7.3.10.1. Company overview
- 7.3.10.2. Financial performance
- 7.3.10.3. Type benchmarking
- 7.3.10.4. Strategic initiatives
- 7.3.11. Bioxis Pharmaceutical
- 7.3.11.1. Company overview
- 7.3.11.2. Financial performance
- 7.3.11.3. Type benchmarking
- 7.3.11.4. Strategic initiatives
- 7.3.12. Sinclair Pharma; Laboratories
- 7.3.12.1. Company overview
- 7.3.12.2. Financial performance
- 7.3.12.3. Type benchmarking
- 7.3.12.4. Strategic initiatives
- 7.3.13. Vivacy; Bohus Biotech AB
- 7.3.13.1. Company overview
- 7.3.13.2. Financial performance
- 7.3.13.3. Type benchmarking
- 7.3.13.4. Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook